Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manabu Okada

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
The Journal of Clinical Endocrinology and Metabolism|March 28, 2023
Possible Advantage of Glucagon-Like Peptide 1 Receptor Agonists for Kidney Transplant Recipients With Type 2 DiabetesTetsuhiko Sato, Yoshinori Azuma, Chikafumi Ozone, et al.
Clinical and Experimental Nephrology|July 11, 2026
Early glomerular capillary C4d is associated with poor graft function in kidney transplant recipients with preformed donor-specific antibodiesYuki Shimamoto, Manabu Okada, Takahisa Hiramitsu, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 21, 2011
Tertiary hyperparathyroidism resistant to cinacalcet treatmentManabu Okada, Yoshihiro Tominaga, Kumiko Izumi, et al.
Transplantation Proceedings|May 7, 2019
Everolimus-based Immunosuppression Possibly Suppresses Mean Fluorescence Intensity Values of De Novo Donor-specific Antibodies After Primary Kidney TransplantationShunji Narumi, Yoshihiko Watarai, Norihiko Goto, et al.
Renal Failure|March 24, 2025
Urinary Basigin/CD147 is a useful marker of acute T cell-mediated rejection in kidney transplant recipientsKenta Futamura, Makoto Tsujita, Tomoki Kosugi, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 4, 2006
A toxicogenomic approach revealed hepatic gene expression changes mechanistically linked to drug-induced hemolytic anemiaMasatomo Rokushima, Kazuo Omi, Akiko Araki, et al.
International Immunopharmacology|January 3, 2021
Optimal blood levels of (extended-release) tacrolimus in living donor kidney transplantation to prevent de novo donor-specific antibody production: A retrospective cohort studyTakahisa Hiramitsu, Toshihide Tomosugi, Kenta Futamura, et al.
Chemical Research in Toxicology|May 27, 2008
Transcriptomic analysis of nephrotoxicity induced by cephaloridine, a representative cephalosporin antibioticMasatomo Rokushima, Kae Fujisawa, Naoko Furukawa, et al.
BMC Nephrology|June 16, 2022
Elevated parathyroid hormone one year after kidney transplantation is an independent risk factor for graft loss even without hypercalcemiaManabu Okada, Yoshihiro Tominaga, Tetsuhiko Sato, et al.
Kidney International Reports|December 13, 2021
Adult Living-Donor Kidney Transplantation, Donor Age, and Donor-Recipient AgeTakahisa Hiramitsu, Toshihide Tomosugi, Kenta Futamura, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
The Journal of Clinical Endocrinology and Metabolism|March 28, 2023
Possible Advantage of Glucagon-Like Peptide 1 Receptor Agonists for Kidney Transplant Recipients With Type 2 DiabetesTetsuhiko Sato, Yoshinori Azuma, Chikafumi Ozone, et al.
Clinical and Experimental Nephrology|July 11, 2026
Early glomerular capillary C4d is associated with poor graft function in kidney transplant recipients with preformed donor-specific antibodiesYuki Shimamoto, Manabu Okada, Takahisa Hiramitsu, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 21, 2011
Tertiary hyperparathyroidism resistant to cinacalcet treatmentManabu Okada, Yoshihiro Tominaga, Kumiko Izumi, et al.
Transplantation Proceedings|May 7, 2019
Everolimus-based Immunosuppression Possibly Suppresses Mean Fluorescence Intensity Values of De Novo Donor-specific Antibodies After Primary Kidney TransplantationShunji Narumi, Yoshihiko Watarai, Norihiko Goto, et al.
Renal Failure|March 24, 2025
Urinary Basigin/CD147 is a useful marker of acute T cell-mediated rejection in kidney transplant recipientsKenta Futamura, Makoto Tsujita, Tomoki Kosugi, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 4, 2006
A toxicogenomic approach revealed hepatic gene expression changes mechanistically linked to drug-induced hemolytic anemiaMasatomo Rokushima, Kazuo Omi, Akiko Araki, et al.
International Immunopharmacology|January 3, 2021
Optimal blood levels of (extended-release) tacrolimus in living donor kidney transplantation to prevent de novo donor-specific antibody production: A retrospective cohort studyTakahisa Hiramitsu, Toshihide Tomosugi, Kenta Futamura, et al.
Chemical Research in Toxicology|May 27, 2008
Transcriptomic analysis of nephrotoxicity induced by cephaloridine, a representative cephalosporin antibioticMasatomo Rokushima, Kae Fujisawa, Naoko Furukawa, et al.
BMC Nephrology|June 16, 2022
Elevated parathyroid hormone one year after kidney transplantation is an independent risk factor for graft loss even without hypercalcemiaManabu Okada, Yoshihiro Tominaga, Tetsuhiko Sato, et al.
Kidney International Reports|December 13, 2021
Adult Living-Donor Kidney Transplantation, Donor Age, and Donor-Recipient AgeTakahisa Hiramitsu, Toshihide Tomosugi, Kenta Futamura, et al.
Pageof 10